4//SEC Filing
Mortensen Eric R. 4
Accession 0001144204-19-040380
CIK 0001175151other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 2:35 PM ET
Size
19.2 KB
Accession
0001144204-19-040380
Insider Transaction Report
Form 4
Mortensen Eric R.
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-08-14−5,000→ 35,000 totalExercise: $4.50Exp: 2027-05-11→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2019-08-14$4.50/sh+5,000$22,500→ 148,932 total
Footnotes (2)
- [F1]Includes (i) the following Restricted Stock Units ("RSUs") that will be settled into common stock upon a "Change In Control," as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 20,000 RSUs granted on March 15, 2018 and (b) 100,000 RSUs granted on May 11, 2017; (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant and the first and second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and that will be settled into common stock upon vesting: (a) 8,134 RSUs granted on July 22, 2019 and unvested as of the date hereof, (b) 3,080 RSUs granted on March 4, 2019 and unvested as of the date hereof and (c) 4,667 RSUs granted on February 28, 2018 and unvested as of the date hereof; and (iii) 13,051 shares of common stock owned by the reporting person, inclusive of the 5,000 shares of common stock reported on this Form 4.
- [F2]The option, representing a right to purchase a total of 40,000 shares of common stock, became exercisable as to one-half of the award on each of the first anniversary of the date of grant and the second anniversary of the date of grant.
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001708454
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 2:35 PM ET
- Size
- 19.2 KB